Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
14 authors at 6 institutions in 4 countries.
Georgios MiliotisAntimicrobial Resistance and Microbial Ecology Group, School of Medicine, University of Galway, Galway, Ireland.ORCID 0000-0002-0944-2206
Pratyay SenguptaDepartment of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, Tamil Nadu, India.ORCID 0000-0002-0184-9335
Asif HameedDivision of Microbiology and Biotechnology, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.ORCID 0000-0003-4445-7080
Maria ChuvochinaThe University of Queensland, School of Chemistry and Molecular Biosciences, Australian Centre for Ecogenomics, Brisbane, Australia.ORCID 0000-0002-3977-6012
Francesca McDonaghAntimicrobial Resistance and Microbial Ecology Group, School of Medicine, University of Galway, Galway, Ireland.ORCID 0000-0002-0830-4899
Anna C SimpsonBiotechnology and Planetary Protection Group, Jet Propulsion Laboratory, California Institute of Technology, Pasadena, California, USA.
Ceth W ParkerBiotechnology and Planetary Protection Group, Jet Propulsion Laboratory, California Institute of Technology, Pasadena, California, USA.
Nitin K SinghBiotechnology and Planetary Protection Group, Jet Propulsion Laboratory, California Institute of Technology, Pasadena, California, USA.
Punchappady D RekhaDivision of Microbiology and Biotechnology, Yenepoya Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, India.ORCID 0000-0002-9187-6395
Dearbháile MorrisAntimicrobial Resistance and Microbial Ecology Group, School of Medicine, University of Galway, Galway, Ireland.
Karthik RamanDepartment of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, Tamil Nadu, India.ORCID 0000-0002-9311-7093
Nikos C KyrpidesUS Department of Energy Joint Genome Institute, Berkeley, California, USA.ORCID 0000-0002-6131-0462
Philip HugenholtzThe University of Queensland, School of Chemistry and Molecular Biosciences, Australian Centre for Ecogenomics, Brisbane, Australia.ORCID 0000-0001-5386-7925
Kasthuri VenkateswaranBiotechnology and Planetary Protection Group, Jet Propulsion Laboratory, California Institute of Technology, Pasadena, California, USA.ORCID 0000-0002-6742-0873
Jet Propulsion Laboratory · USOllscoil na Gaillimhe – University of Galway · IEIndian Institute of Technology Madras · INThe University of Queensland · AUYenepoya University · INLawrence Berkeley National Laboratory · US
Funding
Australian Research Council Discovery Project DP220100900National Aeronautics and Space Administration (NASA) 2012 Space Biology NNH12ZTT001N grant no. 19-12829-26University of Galway (NUI Galway) FutureCare Seed FundU.S. Department of Energy Joint Genome Institute, DOE Office of Science User Facility, U.S. Department of Energy operated under Contract No. DE-AC02-05CH11231
6 · The paper itself
Abstract
A comprehensive microbial surveillance was conducted at NASA's Mars 2020 spacecraft assembly facility (SAF), where whole-genome sequencing (WGS) of 110 bacterial strains was performed. One isolate, designated 179-BFC-A-HS IMPORTANCE: The significance of this research extends to understanding microbial survival and adaptation in oligotrophic environments, such as those found in SAF. Whole-genome sequencing of several strains isolated from Mars 2020 mission assembly cleanroom facilities, including the discovery of the novel species
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Novel spore-forming species exhibiting intrinsic resistance to third- and fourth-generation cephalosporins and description of · full record | Socratic